Aromatase inhibitors combined with aspirin to prevent lung cancer in preclinical models.
作者信息
Young Patricia A, Pietras Richard J
机构信息
Department of Medicine, Division of Hematology-Oncology and Jonsson Comprehensive Cancer Center, UCLA David Geffen School of Medicine, Los Angeles, CA, USA.
出版信息
Transl Lung Cancer Res. 2018 Dec;7(Suppl 4):S373-S376. doi: 10.21037/tlcr.2018.09.17.
Abstract
摘要
相似文献
1
Aromatase inhibitors combined with aspirin to prevent lung cancer in preclinical models.
Transl Lung Cancer Res. 2018 Dec;7(Suppl 4):S373-S376. doi: 10.21037/tlcr.2018.09.17.
2
Preclinical Evidence for Combined Use of Aromatase Inhibitors and NSAIDs as Preventive Agents of Tobacco-Induced Lung Cancer.
J Thorac Oncol. 2018 Mar;13(3):399-412. doi: 10.1016/j.jtho.2017.11.126. Epub 2017 Dec 9.
3
Tamoxifen and aromatase inhibitors differentially affect vascular endothelial growth factor and endostatin levels in women with breast cancer.
Clin Cancer Res. 2008 May 15;14(10):3070-6. doi: 10.1158/1078-0432.CCR-07-4640.
4
[Preclinical evaluation of aromatase inhibitors antitumor activity].
Bull Cancer. 2000 Dec;87 Spec No:7-22.
5
Predictions from a preclinical model: studies of aromatase inhibitors and antiestrogens.
Clin Cancer Res. 2003 Jan;9(1 Pt 2):455S-9S.
6
Interactions of antioestrogens and aromatase inhibitors.
Forum (Genova). 2002;12(1):45-59.
7
Current perspectives on aromatase inhibitors in breast cancer.
J Clin Oncol. 1994 Nov;12(11):2460-70. doi: 10.1200/JCO.1994.12.11.2460.
8
Preclinical studies using the intratumoral aromatase model for postmenopausal breast cancer.
Oncology (Williston Park). 1998 Mar;12(3 Suppl 5):36-40.
9
Aromatase in human lung carcinoma.
Steroids. 2011 Jul;76(8):759-64. doi: 10.1016/j.steroids.2011.02.020. Epub 2011 Mar 8.
10
Aromatase inhibitors as potential cancer chemopreventives.
Cancer Epidemiol Biomarkers Prev. 1998 Jan;7(1):65-78.
引用本文的文献
1
Association of CYP19A1 rs28757157 polymorphism with lung cancer risk in the Chinese Han population.
World J Surg Oncol. 2022 Dec 16;20(1):400. doi: 10.1186/s12957-022-02868-9.
2
Sex Hormones and Lung Inflammation.
Adv Exp Med Biol. 2021;1304:259-321. doi: 10.1007/978-3-030-68748-9_15.
本文引用的文献
1
Randomized phase II study of fulvestrant and erlotinib compared with erlotinib alone in patients with advanced or metastatic non-small cell lung cancer.
Lung Cancer. 2018 Sep;123:91-98. doi: 10.1016/j.lungcan.2018.06.013. Epub 2018 Jun 22.
2
Projections in Breast and Lung Cancer Mortality among Women: A Bayesian Analysis of 52 Countries Worldwide.
Cancer Res. 2018 Aug 1;78(15):4436-4442. doi: 10.1158/0008-5472.CAN-18-0187.
3
The Role of the Estrogen Pathway in the Tumor Microenvironment.
Int J Mol Sci. 2018 Feb 19;19(2):611. doi: 10.3390/ijms19020611.
4
Preclinical Evidence for Combined Use of Aromatase Inhibitors and NSAIDs as Preventive Agents of Tobacco-Induced Lung Cancer.
J Thorac Oncol. 2018 Mar;13(3):399-412. doi: 10.1016/j.jtho.2017.11.126. Epub 2017 Dec 9.
5
Antiestrogen use in breast cancer patients reduces the risk of subsequent lung cancer: A population-based study.
Cancer Epidemiol. 2017 Jun;48:22-28. doi: 10.1016/j.canep.2017.02.010. Epub 2017 Mar 17.
6
Cancer Statistics, 2017.
CA Cancer J Clin. 2017 Jan;67(1):7-30. doi: 10.3322/caac.21387. Epub 2017 Jan 5.
7
Meta-analysis of aspirin use and risk of lung cancer shows notable results.
Eur J Cancer Prev. 2016 Jul;25(4):259-68. doi: 10.1097/CEJ.0000000000000176.
8
Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial.
Lancet. 2014 Mar 22;383(9922):1041-8. doi: 10.1016/S0140-6736(13)62292-8. Epub 2013 Dec 12.
9
Prevention of tobacco carcinogen-induced lung cancer in female mice using antiestrogens.
Carcinogenesis. 2012 Nov;33(11):2181-9. doi: 10.1093/carcin/bgs260. Epub 2012 Aug 2.
10
Exemestane for breast-cancer prevention in postmenopausal women.
N Engl J Med. 2011 Jun 23;364(25):2381-91. doi: 10.1056/NEJMoa1103507. Epub 2011 Jun 4.
Zotero 插件